Skip to content

Net Income at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$92.53M+37.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$166.56M+1.8%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
-$94.39M-28.9%
AbbVie logo
AbbVieABBV
$697M-45.9%
Revvity logo
RevvityRVTY
$40.72M-3.6%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's net income?
Arrowhead Research (ARWR) reported net income of -$137.57M in Q1 2026.
How has Arrowhead Research's net income changed year-over-year?
Arrowhead Research's net income decreased by 137.4% year-over-year, from $367.86M to -$137.57M.
What is the long-term trend for Arrowhead Research's net income?
Over 4 years (2021 to 2025), Arrowhead Research's net income has grown at a -32.0% compound annual growth rate (CAGR), from -$140.85M to $30.11M.
What does net income mean?
The total profit or loss a company generates after all expenses are paid.
How do you interpret net income?
An increase indicates higher profitability, while a decrease suggests declining margins or rising costs.
How does net income compare across companies?
Standard across all public companies, though biotech firms often report losses during R&D phases.